Sagimet Biosciences Inc
F:0O2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sagimet Biosciences Inc
F:0O2
|
US |
|
H
|
Harmony Gold Mining Company Ltd
XMUN:HAM1
|
ZA |
|
G
|
Gilead Sciences Inc
XMUN:GIS
|
US |
|
S
|
Sinopharm Group Co Ltd
XBER:X2S
|
CN |
|
S
|
Sekisui House Ltd
SWB:SPH1
|
JP |
|
E
|
Edgewell Personal Care Co
XMUN:EGZ
|
US |
|
SK Inc
KRX:03473K
|
KR |
|
Naturgy Energy Group SA
F:GANA
|
ES |
|
Bentley Systems Inc
F:BS81
|
US |
|
PTC Therapeutics Inc
F:BH3
|
US |
|
Exlservice Holdings Inc
NASDAQ:EXLS
|
US |
|
P
|
Pop Mart International Group Ltd
F:735
|
CN |
|
Brookfield Wealth Solutions Ltd
TSX:BNT
|
BM |
|
Brookfield Wealth Solutions Ltd
F:9JG
|
BM |
Wall St Price Targets
0O2 Price Targets Summary
Sagimet Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
0O2 is 16.75 EUR with a low forecast of 4.64 EUR and a high forecast of 33.76 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0O2's stock price target?
Price Target
16.75
EUR
According to Wall Street analysts, the average 1-year price target for
0O2 is 16.75 EUR with a low forecast of 4.64 EUR and a high forecast of 33.76 EUR.